Matthew Lang

Matthew Lang is the Chief Business and Legal Officer at Lyell Immunopharma, a role assumed in July 2023. Prior to this, Matthew served as the Chief Administrative and Legal Officer at Myovant Sciences from July 2017 to July 2023, where Matthew also held the positions of General Manager for Myovant Sciences GmbH and General Counsel & Corporate Secretary for Myovant Sciences, Inc. Matthew was a member of the Board of Directors at United Way Bay Area from 2015 to 2018 and worked as Vice President of Legal at Gilead Sciences from 2009 to 2017. Earlier in Matthew's career, Matthew practiced as an attorney at Dechert LLP from 2002 to 2009. Academically, Matthew earned a Juris Doctorate from the University of Pennsylvania Carey Law School and a Bachelor of Arts in Classical and Ancient Studies from Queen's University.